Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

OPTN

OptiNose Inc

May 15 • 04:00PM ET

1.18

Dollar change +0.05
Percentage change 4.87	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO IWC VTWG URTY VTHR UWM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.27	Insider Own	28.62%	Shs Outstand	112.40M	Perf Week	13.94%
Market Cap	133.95M	Forward P/E	-	EPS next Y	-0.07	Insider Trans	-0.33%	Shs Float	80.68M	Perf Month	8.72%
Income	-30.75M	PEG	-	EPS next Q	-0.08	Inst Own	57.03%	Short Float	7.34%	Perf Quarter	-12.22%
Sales	74.02M	P/S	1.81	EPS this Y	21.91%	Inst Trans	-0.27%	Short Ratio	4.93	Perf Half Y	-2.87%
Book/sh	-0.88	P/B	-	EPS next Y	73.08%	ROA	-30.97%	Short Interest	5.92M	Perf Year	-39.23%
Cash/sh	0.46	P/C	2.59	EPS next 5Y	-	ROE	-	52W Range	0.80 - 2.10	Perf YTD	-8.14%
Dividend Est.	-	P/FCF	-	EPS past 5Y	34.78%	ROI	-97.83%	52W High	-43.57%	Beta	-0.09
Dividend TTM	-	Quick Ratio	2.17	Sales past 5Y	95.85%	Gross Margin	88.57%	52W Low	48.12%	ATR (14)	0.12
Dividend Ex-Date	-	Current Ratio	2.48	EPS Y/Y TTM	63.15%	Oper. Margin	-22.23%	RSI (14)	54.12	Volatility	11.43% 12.62%
Employees	132	Debt/Eq	-	Sales Y/Y TTM	0.90%	Profit Margin	-41.55%	Recom	1.00	Target Price	3.50
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	25.92%	Payout	-	Rel Volume	0.48	Prev Close	1.13
Sales Surprise	0.92%	EPS Surprise	1.14%	Sales Q/Q	25.61%	Earnings	May 14 BMO	Avg Volume	1.20M	Price	1.18
SMA20	19.36%	SMA50	-10.56%	SMA200	-7.93%	Trades		Volume	568,969	Change	4.87%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-11-24	Initiated	H.C. Wainwright	Buy	$5
Aug-21-23	Initiated	Lake Street	Buy	$3
Oct-21-22	Resumed	Jefferies	Buy	$5
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$17
Dec-18-19	Initiated	Cowen	Outperform	$25
Aug-08-18	Initiated	Cantor Fitzgerald	Overweight

May-15-24 05:15AM	Q1 2024 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents)
03:07AM	OptiNose Inc (OPTN) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ... (GuruFocus.com)
May-14-24 11:53AM	OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:10AM	OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:07AM	OptiNose: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Loading…
07:00AM	Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights (GlobeNewswire)
May-10-24 03:51PM	OptiNose Inc (OPTN) Announces $55 Million Financing Round Amidst Revenue Projections (GuruFocus.com) +8.93%
02:56PM	Optinose Announces Reporting Date for First Quarter 2024 Financial Results (GlobeNewswire)
May-09-24 07:00AM	Optinose Announces $55 Million Registered Direct Offering (GlobeNewswire) +7.69%
May-02-24 10:01AM	Will OptiNose (OPTN) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-25-24 10:51AM	Why Is OptiNose (OPTN) Stock Up 12% Today? (InvestorPlace)
07:00AM	Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million (GlobeNewswire)
Apr-04-24 04:01PM	Optinose to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-15-24 03:34PM	XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps (GlobeNewswire)
Mar-08-24 09:50AM	OptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:41PM	Loading…
Mar-07-24 09:41PM	Q4 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents)
01:54PM	OptiNose Inc (OPTN) Reports Decline in 2023 Revenue Amidst Preparations for Potential XHANCE ... (GuruFocus.com)
12:52PM	OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:15AM	OptiNose (OPTN) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:33AM	OptiNose: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights (GlobeNewswire)
Feb-29-24 04:40PM	Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results (GlobeNewswire)
Jan-18-24 12:00PM	Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice (GlobeNewswire)
Dec-06-23 07:00AM	Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE (GlobeNewswire) -16.33%
Nov-22-23 09:00AM	Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-11-23 11:37AM	OptiNose, Inc. (NASDAQ:OPTN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:05AM	OptiNose Inc (OPTN) Reports Q3 2023 Financial Results with Improved Operating Efficiency (GuruFocus.com)
07:25AM	OptiNose: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Optinose Reports Third Quarter 2023 Financial Results and Operational Updates (GlobeNewswire)
Oct-27-23 08:00AM	Optinose Announces Reporting Date for Third Quarter 2023 Financial Results (GlobeNewswire)
12:00PM	Loading…
Oct-24-23 12:00PM	OptiNose (OPTN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-22-23 09:01AM	Optinose to Present at the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-12-23 09:58AM	OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 08:54PM	Q2 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents) +6.90%
08:25AM	OptiNose (OPTN) Q2 Earnings and Revenues Top Estimates (Zacks)
07:27AM	OptiNose: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Optinose Reports Second Quarter 2023 Financial Results and Operational Updates (GlobeNewswire)
Aug-09-23 07:55PM	Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -5.69%
Jul-27-23 07:00AM	Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million (GlobeNewswire)
Jul-07-23 08:28AM	When Will OptiNose, Inc. (NASDAQ:OPTN) Breakeven? (Simply Wall St.)
Jun-16-23 04:08PM	Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-10-23 08:16AM	OptiNose, Inc. (NASDAQ:OPTN) is definitely on the radar of institutional investors who own 39% of the company (Simply Wall St.)
Jun-02-23 01:00PM	Optinose to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-14-23 08:08AM	US$4.17: That's What Analysts Think OptiNose, Inc. (NASDAQ:OPTN) Is Worth After Its Latest Results (Simply Wall St.)
May-11-23 10:43PM	Q1 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents) +6.45%
08:55AM	OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:54AM	OptiNose: Q1 Earnings Snapshot (AP Finance)
07:00AM	Optinose Reports First Quarter 2023 Financial Results and Operational Updates (GlobeNewswire)
May-04-23 07:00AM	Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE (GlobeNewswire) +11.43%
May-01-23 04:30PM	Optinose Announces Reporting Date for First Quarter 2023 Financial Results (GlobeNewswire)
Apr-18-23 12:43PM	OptiNose, Inc.'s (NASDAQ:OPTN) Business Is Trailing The Industry But Its Shares Aren't (Simply Wall St.)
08:00AM	Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-12-23 04:00PM	Optinose to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-11-23 07:29AM	OptiNose, Inc. (NASDAQ:OPTN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-09-23 06:24AM	We're Not Very Worried About OptiNose's (NASDAQ:OPTN) Cash Burn Rate (Simply Wall St.) -8.42%
Mar-07-23 11:22PM	Q4 2022 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents)
08:35AM	OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights (GlobeNewswire)
Mar-06-23 02:03AM	Silence Therapeutics PLC Sponsored ADR (SLN) Stock Jumps 9.3%: Will It Continue to Soar? (Zacks) +5.56%
Feb-28-23 04:30PM	Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results (GlobeNewswire)
Feb-21-23 02:29PM	Bucks County firm seeks to expand approval for flagship product (American City Business Journals)
07:00AM	Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion (GlobeNewswire)
Jan-31-23 12:03PM	Optinose CEO Peter Miller resigns after 13 years; successor named (American City Business Journals)
07:00AM	Optinose Announces CEO Transition and Business Update (GlobeNewswire)
Dec-27-22 09:27AM	OptiNose, Inc.'s (NASDAQ:OPTN) top owners are private equity firms with 37% stake, while33% is held by institutions (Simply Wall St.)
Dec-15-22 04:30PM	Optinose Appoints Paul Spence as Chief Commercial Officer (GlobeNewswire)
Dec-09-22 08:00AM	Optinose Announces Departure of Acting Chief Financial Officer (GlobeNewswire) -7.94%
Nov-30-22 07:00AM	Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-22-22 02:24PM	Bucks County health care company expects to raise $50M (American City Business Journals) +5.71%
Nov-21-22 08:30AM	Optinose Announces Pricing of Public Offering of Common Stock and Warrants (GlobeNewswire) -7.89%
06:12AM	Optinose Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire)
Nov-16-22 05:24AM	Analysts Are More Bearish On OptiNose, Inc. (NASDAQ:OPTN) Than They Used To Be (Simply Wall St.)
Nov-12-22 07:54AM	OptiNose Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Nov-10-22 08:15AM	OptiNose (OPTN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -15.08%
08:00AM	Edited Transcript of OPTN.OQ earnings conference call or presentation 10-Nov-22 1:00pm GMT (Thomson Reuters StreetEvents)
07:00AM	Optinose Reports Third Quarter 2022 Financial Results and Operational Updates (GlobeNewswire)
Nov-09-22 03:00PM	Optinose Announces ReOpen2 Presentation at the American College of Asthma, Allergy, and Immunology (ACAAI) 2022 Annual Scientific Meeting (GlobeNewswire) -6.34%
Nov-07-22 03:00PM	Optinose Announces Reporting Date for Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-21-22 07:00AM	Optinose Announces Late Breaking Abstract Podium Presentation at IDWeek 2022 (GlobeNewswire)
Oct-16-22 08:24AM	Shareholders in OptiNose (NASDAQ:OPTN) are in the red if they invested five years ago (Simply Wall St.)
Sep-18-22 10:44AM	When Can We Expect A Profit From OptiNose, Inc. (NASDAQ:OPTN)? (Simply Wall St.)
Sep-06-22 12:00PM	Optinose Announces ReOpen1 Abstract Selected for Presentation at the American Rhinologic Society Annual Meeting (GlobeNewswire)
Aug-17-22 10:00AM	2 Stocks That Should Perform Well Even if Consumers Pull In Their Horns (TheStreet.com)
Aug-11-22 08:15AM	OptiNose (OPTN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Optinose Reports Second Quarter 2022 Financial Results and Operational Updates (GlobeNewswire)
Aug-08-22 04:20PM	Optinose Announces Reporting Date for Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-14-22 08:45AM	10 Best Penny Stocks to Buy in July (Insider Monkey)
Jul-13-22 10:58AM	Pooled Data Show Optinose's XHANCE Cut Sinusitis Flares By 66% (Benzinga)
07:44AM	Organogenesis (ORGO) Stock Jumps 5.3%: Will It Continue to Soar? (Zacks)
07:00AM	Optinose Announces that XHANCE Significantly Reduced Incidence of Exacerbations for Patients with Chronic Sinusitis in Landmark ReOpen Program (GlobeNewswire)
Jul-08-22 08:23AM	Optinose Shared Additional Encouraging Data From Late-Stage Chronic Sinusitis Studies (Benzinga)
07:00AM	Optinose Announces Additional Positive Results from ReOpen2 and Initial Results from Pooled Analyses of Both Trials in the ReOpen Program (GlobeNewswire)
Jun-13-22 11:10AM	Optinose Stock Moves Higher On Positive Second Chronic Sinusitis Phase 3 Trial (Benzinga) +41.08%
07:00AM	Optinose Announces Positive Top-line Results of ReOpen2, its second Phase 3 Clinical Trial of XHANCE for Treatment of Chronic Sinusitis (GlobeNewswire)
Jun-03-22 07:00AM	Optinose Announces Departure of Chief Financial Officer (GlobeNewswire)
May-12-22 08:15AM	OptiNose (OPTN) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.38%
07:00AM	Optinose Reports First Quarter 2022 Financial Results and Operational Updates (GlobeNewswire)
May-10-22 07:15AM	Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-09-22 05:35PM	Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -9.26%
May-05-22 05:00PM	Optinose Announces Reporting Date for First Quarter 2022 Financial Results (GlobeNewswire)

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mahmoud Ramy A	Chief Executive Officer	Mar 18 '24	Sale	1.88	19,198	36,092	1,331,278	Mar 19 12:43 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Mar 18 '24	Sale	1.88	15,059	28,311	602,268	Mar 19 12:45 PM
Krick Anthony J	Chief Accounting Officer	Mar 18 '24	Sale	1.88	2,345	4,409	143,988	Mar 19 12:46 PM
Mahmoud Ramy A	Chief Executive Officer	Jan 31 '24	Sale	1.31	52,875	69,266	548,387	Feb 01 02:43 PM
Mahmoud Ramy A	Chief Executive Officer	Dec 18 '23	Sale	1.15	11,114	12,781	509,728	Dec 20 12:21 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Dec 18 '23	Sale	1.15	5,005	5,756	333,511	Dec 20 12:20 PM
Mahmoud Ramy A	Chief Executive Officer	Sep 18 '23	Sale	1.37	11,083	15,184	514,729	Sep 19 07:05 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Sep 18 '23	Sale	1.37	4,991	6,838	334,699	Sep 19 07:04 PM
Mahmoud Ramy A	Chief Executive Officer	Jun 16 '23	Sale	1.15	3,543	4,074	519,699	Jun 20 01:03 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Jun 16 '23	Sale	1.15	1,516	1,743	335,873	Jun 20 01:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OPTN

OptiNose Inc

Upgrade your FINVIZ experience